Hyperfine, Inc. (HYPR)
NASDAQ: HYPR · IEX Real-Time Price · USD
0.879
+0.018 (2.09%)
At close: May 24, 2024, 4:00 PM
0.908
+0.029 (3.33%)
After-hours: May 24, 2024, 7:57 PM EDT

Hyperfine Revenue

Hyperfine had revenue of $11.69M in the twelve months ending March 31, 2024, with 47.25% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $3.30M with 25.05% year-over-year growth. In the year 2023, Hyperfine had annual revenue of $11.03M with 61.90% growth.

Revenue (ttm)
$11.69M
Revenue Growth
+47.25%
P/S Ratio
5.41
Revenue / Employee
$89,252
Employees
131
Market Cap
63.29M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202311.03M4.22M61.90%
Dec 31, 20226.81M5.32M355.48%
Dec 31, 20211.50M1.20M408.84%
Dec 31, 2020294.00K--
Dec 31, 20190--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Neuronetics 73.23M
Champions Oncology 49.22M
Turnstone Biologics 19.31M
Asensus Surgical 8.72M
InspireMD 6.48M
Ikena Oncology 3.85M
Revenue Rankings